Several unsupervised studies, aiming to define the molecular subtypes of ovarian cancer by gene expression profiling, univocally identified CXCL9 and the other CXCR3 chemokines as marker genes of an inflammation-enriched subtype [14–18]. This evidence concerns the gene CXCL9 and ovarian cancer.